RNA Affinity Purification Using Conductivity Control for dsRNA Reduction
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The challenge in manufacturing RNA-based therapeutics and vaccines is the presence of impurities such as double-stranded RNA (dsRNA) and short abortive mRNA, which inhibit protein translation and decrease safety/efficacy, necessitating improved purification methods to achieve high yields with reduced impurities.
Innovation Solution
A method involving adjusting the conductivity of an RNA transcription product composition to less than 20 mS/cm and purifying it using a polynucleotide affinity column to obtain a purified RNA transcription product with increased purity, achieved by diluting the crude RNA transcript composition with a conductivity decreasing agent.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If traditional purification methods are used, then the purification process is simple, but the purity of RNA transcription product is insufficient with high levels of dsRNA and short abortive mRNA impurities
Solution Approach 1:
The patent applies preliminary action by adjusting the conductivity of the input composition to below 20 mS/cm before loading onto the polynucleotide affinity column. This pre-treatment step optimizes the binding conditions for full-length transcripts while preventing impurities like dsRNA and short abortive mRNA from co-binding, thereby achieving high purity (≥60% to 99.9%) without requiring multiple complex purification steps
Solution Approach 2:
The patent utilizes parameter changes by controlling the conductivity of the input composition as a critical parameter. By adjusting conductivity to below 20 mS/cm through dilution or buffer exchange, the method creates optimal conditions for selective binding of full-length transcripts to the polynucleotide affinity column, effectively separating them from impurities based on their different binding characteristics under these controlled conditions
2Manufacturing precision
If conductivity adjustment and polynucleotide affinity column purification are used, then the purity increases to at least 60% to 99.9%, but the process complexity increases
Solution Approach 1:
The conductivity adjustment step is performed as a preliminary action before column loading, ensuring that the input composition meets the optimal conductivity threshold (<20 mS/cm). This pre-optimization simplifies the overall manufacturing process by preventing impurity binding at the source, making the purification step more efficient and easier to execute consistently
Solution Approach 2:
The patent replaces complex mechanical or multi-step purification systems with a simplified approach based on conductivity control and affinity chromatography. By substituting physical complexity with a controllable chemical parameter (conductivity), the method achieves high purity while maintaining ease of manufacture through a streamlined, single-column purification process
3Manufacturing precision
If the conductivity of the composition is not adjusted, then the process is faster and simpler, but the purification efficiency decreases with lower purity output
Solution Approach 1:
Conductivity adjustment is performed as a preliminary action that can be efficiently executed using automated liquid handling systems or rapid buffer exchange methods. By completing this step before column loading, the method ensures optimal binding conditions are established upfront, preventing the need for time-consuming repeated purification cycles and actually reducing total processing time
Solution Approach 2:
The patent transforms the time-consuming aspect into a controlled parameter optimization step. By adjusting conductivity to a specific threshold (<20 mS/cm), the method creates optimal binding conditions that enhance purification efficiency in a single pass, eliminating the need for multiple sequential purification steps and thereby reducing overall processing time despite the initial adjustment requirement
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The method achieves a purity of at least 60% to 99.9% for the purified RNA transcription product, effectively reducing dsRNA and short abortive mRNA impurities, enhancing the safety and efficacy of RNA-based therapeutics and vaccines.
Implementation Method 1
introducing the RNA transcription product composition to a polynucleotide affinity column; and eluting the RNA transcription product from the column
Data Source
AI summary
Disclosed herein are methods of purifying nucleic acids with reduced impurities. Some such methods include purifying transcribed RNA products, and may result in a reduction in dsRNA and other impurities compared to other methods.